Q-omics provides the consensus-scored LINC02861 profile across patient tissues and cancer cell-line models. LINC02861 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, LINC02861 is differentially expressed in 14, with the highest sampling consensus in THCA. Additionally, LINC02861 RNA expression shows 17,549 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UVM, and THCA as cancer lineages where LINC02861 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02861 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02861 survival associations across molecular data types. LINC02861 RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02861 RNA expression–survival associations across cancer types. High LINC02861 expression shows unfavorable associations in UVM and UCEC, but favorable associations in LUAD, CESC, BRCA and KIRC. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for LINC02861 RNA expression.
This table summarizes LINC02861 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 14. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02861. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02861 shows lower tumor expression in THCA, LUSC, BLCA, LUAD, HNSC and COAD. The THCA box plot shows higher LINC02861 RNA expression in normal versus tumor tissue (log2 FC = −2.570, t-test p < 0.001).
This table shows molecular features associated with LINC02861 in patient tissues and cancer cell lines. In patient samples, LINC02861 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
